OUR STORY
2013
Highlight:
- THINK registered as Non-Profit-Company in South Africa (6 June 2013)
New sites:
- First Clinical Trial Unit (CTU), Durban City Hospital
New projects:
- Start of first clinical trial (OTSUKA)
2014
Highlight:
- Harvard International Health Course hosted at THINK
New sites:
- THINK Head Office Florida rd, Durban
- THINK CTU at Florida rd, Durban
- THINK CTU, King Dinuzulu Hospital
New projects:
- STREAM stage I clinical trial (Vital Strategies/ USAID)
- First Community Engagement project (TB Alliance)
2015
New sites:
- THINK CTU at Doris Goodwin TB Hospital, Pietermaritzburg
New projects:
- Novel Diagnostics: Evaluation of TB Breath Test (AVISA)
- Novel Biomarker study (NIH)
- NC005 clinical trial (TB Alliance)
- NC006 (STAND) clinical trial (TB Alliance)
2016
Highlight:
- First time sub-recipient of programme funding (Global Fund)
New sites:
- THINK CTU at King Dinuzulu Hospital, Durban
New projects:
- STREAM stage II clinical trial (Vital Strategies/ USAID)
- TMC207 Paediatric clinical trial (Janssen)
- National ART Adherence Programme (Global Fund)
2017
Highlight:
- Employment of 228 people at THINK
New sites:
- THINK CTU, Don McKenzie TB Hospital
- Programme Office at University of KwaZulu-Natal, Durban
New projects:
- TB PRACTECAL clinical trial at Doris Goodwin CTU (MSF)
- EDCTP Fellowship in The Netherlands
- Social Science survey (MDR TB prevention in children) (Stellenbosch University)
2018
Highlight:
- THINK won KZN TOP BUSINESS AWARD in the ‘Community and Social Services’ category
Impact:
- 139,106 persons living with HIV reached with treatment support
- Shortened (from 2 years to 9 months) treatment for drug-resistant TB adopted as Standard of Care in South Africa
New sites:
- THINK Head Office, Hillcrest, Durban
New projects:
- SimpliciTB (NC008) clinical trial start (TB Alliance)
- TB PRACTECAL clinical trial, start at Don McKenzie CTU (MSF)
2019
Highlight:
- THINK becomes USAID TB LON partner in South Africa
New sites:
- uMgungundlovu District Office, Pietermaritzburg
New projects:
- TB Advocacy programme (AFSA, Global Fund)
- ART Adherence Support programme (MatCH, USAID)
- Safeguarding Advances in the Fight Against TB (SAFT) programme (USAID TB LON)
- Operational implementation of 6-months treatment for drug-resistant TB (TB REACH)
2020
Highlights:
- USAID TB LON-SAFT programme expanded to uMkhanyakude district in KwaZulu-Natal and the Eastern Cape Province
- Provincial support to the Departments of Health in KwaZulu-Natal and Eastern Cape
- TB Advocacy team’s Key Vulnerable Populations work expanded to Ugu
New sites:
- Head Office moved to larger premises on 4 Lucas Drive, Hillcrest
- THINK CTU built in Hillcrest
- uMkhanyakude District Office, Richards Bay
- eThekwini District Office, Hillcrest
New projects:
- Video Observed Treatment (VOT) to improve TB care (MSF)
- ART preparedness is by Johnson and Johnson
- Paternity Safety trial (UCL)
2021
Highlights:
- THINK’s Key Vulnerable Populations work expanded to Ugu District (Global Fund)
- Satellite Symposia at Union World Conference on Lung Health organised by THINK
New sites:
- uThukela District Office, Ladysmith
- Amajuba District Office, Newcastle
New Projects:
- TB CHAMP clinical trial (University of Stellenbosch)
- Acceptability and Feasibility of Video Observed Treatment (VOT)
2022
Highlight:
- THINK International registered as NGO in Denmark
New sites:
- THINK International Head Office, Copenhagen, Denmark
New projects:
- Palatability of new TB medication (University of Stellenbosch)
- Humanitarian Aid (Solidarity Fund)











